Sex differences in cerebral energy metabolism in Parkinson's disease: A phosphorus magnetic resonance spectroscopic imaging study

被引:19
|
作者
Weiduschat, Nora [1 ]
Mao, Xiangling [1 ]
Beal, M. Flint [1 ]
Nirenberg, Melissa J. [2 ]
Shungu, Dikoma C. [1 ]
Henchcliffe, Claire [1 ]
机构
[1] Weill Cornell Med Coll, New York, NY 10021 USA
[2] NYU, Sch Med, New York, NY 10016 USA
关键词
Parkinson's disease; Sex differences; Magnetic resonance spectroscopy; Biomarker; Oxidative stress; Mitochondrial dysfunction; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; BRAIN; WOMEN;
D O I
10.1016/j.parkreldis.2014.02.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To test the hypothesis that there are sex differences in cerebral energy metabolism in Parkinson's disease (PD). Methods: Phosphorus magnetic resonance spectroscopy (P-31 MRS) was used to determine high-energy phosphate (phosphocreatine and ATP) and low-energy phosphate (free phosphate) levels in the striatum and temporoparietal cortical gray matter (GM) in 10 men and 10 women with PD, matched for age at onset, disease duration, and UPDRS scores. Results: In the hemisphere more affected by PD, both ATP and high energy phosphate (HEP: phosphocreatine + ATP) content in striatum was 15% lower in men versus women with PD (p = .050 and p = .048, respectively). Similar decreases by 16% in ATP (p = .023) and 12% in HEP (p = .046) were observed in GM in men versus women with PD. In contrast, there were no detectable sex differences in ATP or HEP in healthy age-matched controls. Conclusions: Men with PD have lower levels of ATP and high energy phosphate than women in brain regions affected by PD. These findings suggest that there may be a greater burden of mitochondrial dysfunction in PD in men versus women with PD. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 50 条
  • [41] The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review
    Al-Radaideh, Ali M.
    Rababah, Eman M.
    CLINICAL IMAGING, 2016, 40 (05) : 987 - 996
  • [42] Magnetic resonance imaging markers for early diagnosis of Parkinson's disease
    Marino, Silvia
    Ciurleo, Rosella
    Di Lorenzo, Giuseppe
    Barresi, Marina
    De Salvo, Simona
    Giacoppo, Sabrina
    Bramanti, Alessia
    Lanzafame, Pietro
    Bramanti, Placido
    NEURAL REGENERATION RESEARCH, 2012, 7 (08) : 611 - 619
  • [43] Magnetic resonance imaging markers for early diagnosis of Parkinson's disease
    Silvia Marino
    Rosella Ciurleo
    Giuseppe Di Lorenzo
    Marina Barresi
    Simona De Salvo
    Sabrina Giacoppo
    Alessia Bramanti
    Pietro Lanzafame
    Placido Bramanti
    Neural Regeneration Research, 2012, 7 (08) : 611 - 619
  • [44] Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?
    Duncan, Gordon W.
    Firbank, Michael J.
    O'Brien, John T.
    Burn, David J.
    MOVEMENT DISORDERS, 2013, 28 (04) : 425 - 438
  • [45] Resting State Functional Magnetic Resonance Imaging in Parkinson’s Disease
    Janey Prodoehl
    Roxana G. Burciu
    David E. Vaillancourt
    Current Neurology and Neuroscience Reports, 2014, 14
  • [46] Axial signs and magnetic resonance imaging correlates in Parkinson's disease
    Acharya, Hernish J.
    Bouchard, Thomas P.
    Emery, Derek J.
    Camicioli, Richard M.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 (01) : 56 - 61
  • [47] Imaging cerebral 2-ketoisocaproate metabolism with hyperpolarized 13C Magnetic Resonance Spectroscopic Imaging
    Butt, Sadia A.
    Sogaard, Lise V.
    Magnusson, Peter O.
    Lauritzen, Mette H.
    Laustsen, Christoffer
    Akeson, Per
    Ardenkjaer-Larsen, Jan H.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (08): : 1508 - 1514
  • [48] Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease
    Lipp, Axel
    Trbojevic, Radmila
    Paul, Friedemann
    Fehlner, Andreas
    Hirsch, Sebastian
    Scheel, Michael
    Noack, Cornelia
    Braun, Juergen
    Sack, Ingolf
    NEUROIMAGE-CLINICAL, 2013, 3 : 381 - 387
  • [49] Effect of cost in the treatment of Parkinson's disease: a functional magnetic resonance imaging study.
    Espay, A. J.
    Norris, M.
    Eliassen, J.
    Dwivedi, A.
    Smith, M.
    Lang, A. E.
    Fleck, D.
    Linke, M.
    Szaflarski, J. P.
    MOVEMENT DISORDERS, 2013, 28 (10) : E9 - E9
  • [50] STUDY OF RESTING-STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING IN PATIENTS WITH PARKINSON'S DISEASE
    Qiao, Chen
    LI, Xiaosheng
    Hou, Changlong
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 1655 - 1659